Cardiology Research Today is a free monthly online journal that collates and summarizes the latest research about Cardiology, including details on fitness, heart disease, medications.

Comparison of the cardiac electrophysiological effects between doxazosin and bunazosin.

Lee AS, Chen WP, Su MJ

Institute of Pharmacology, College of Medicine, National Taiwan University, No.1, Sec.1, Jen-Ai Rd., Taipei 100, Taiwan, ROC.

In Langendorff-perfused adult rat heart with constant pressure at 80 mmHg, we found doxazosin, an alpha(1) adrenoceptor blocker, at 10 muM prolonged PR interval and induced occasional arrhythmia followed by complete inhibition of the sinus rhythm, whereas bunazosin, another alpha(1)-blocker, at same concentration did not. The results of voltage-clamp study showed that, at the concentration of 10 muM, doxazosin inhibited I (Na), I ( (Ca,L) ), I (to), and Iss without changing I (k1) but bunazosin only inhibited I ( (Ca,L) ) about 30%. Doxazosin also caused markedly negative shift of the I (Na) inactivation curve. In current-clamp study, doxazosin prolonged action potential duration in association with the decreased action potential amplitude and upstroke velocity, whereas bunazosin did not. We hypothesize that doxazosin-induced arrhythmia may result from the heterogeneous or different level of I ( (Ca,L) ) blockade of AV nodal tissue. In conclusion, the present study suggests that bunazosin is safer than doxazosin for long-term treatment in view of electrophysiological effect. However, the underlying mechanism of doxazosin induced nodal arrhythmia is still needed to be determined.

Published 4 June 2008 in J Biomed Sci, 15(4): 519-28.
Full-text of this article is available online (may require subscription).

© 2005-2008 Cardiology Research Today. All Rights Reserved.